This MSCA project aims at overcoming the limitations of the current available strategies for the treatment of post-ischemic stroke effects by introducing 'BIONICS', which represents a biomimetic and neuroprotective delivery nanocapsule. Its novelty lies to the enhanced delivery of various reactive oxygen species (ROS) and reactive nitrogen species (RNS) scavengers across the blood brain barrier (BBB), and the amelioration of the post-ischemic stroke symptoms through hypoxia and oxidative stress regulation.
Brain Stroke: Types, Causes, Pathology, Symptoms, Treatment & Prevention

This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 793644.
© MSCA-Bionics Project. This webpage was designed by Christos Tapeinos for the MSCA project 'BIONICS'.